ArticleCancer research2017

PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1.

Alexandra Lacey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.